1. Home
  2. NTRP vs SYBX Comparison

NTRP vs SYBX Comparison

Compare NTRP & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRP
  • SYBX
  • Stock Information
  • Founded
  • NTRP 1985
  • SYBX N/A
  • Country
  • NTRP United States
  • SYBX United States
  • Employees
  • NTRP N/A
  • SYBX N/A
  • Industry
  • NTRP
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTRP
  • SYBX Health Care
  • Exchange
  • NTRP NYSE
  • SYBX Nasdaq
  • Market Cap
  • NTRP 12.7M
  • SYBX 13.6M
  • IPO Year
  • NTRP N/A
  • SYBX N/A
  • Fundamental
  • Price
  • NTRP $2.10
  • SYBX $1.19
  • Analyst Decision
  • NTRP Hold
  • SYBX
  • Analyst Count
  • NTRP 1
  • SYBX 0
  • Target Price
  • NTRP $5.00
  • SYBX N/A
  • AVG Volume (30 Days)
  • NTRP 295.1K
  • SYBX 12.5K
  • Earning Date
  • NTRP 06-10-2025
  • SYBX 06-10-2025
  • Dividend Yield
  • NTRP N/A
  • SYBX N/A
  • EPS Growth
  • NTRP N/A
  • SYBX N/A
  • EPS
  • NTRP N/A
  • SYBX 0.21
  • Revenue
  • NTRP $501,422.00
  • SYBX N/A
  • Revenue This Year
  • NTRP $354.28
  • SYBX N/A
  • Revenue Next Year
  • NTRP $536.37
  • SYBX N/A
  • P/E Ratio
  • NTRP N/A
  • SYBX $5.49
  • Revenue Growth
  • NTRP 186.93
  • SYBX N/A
  • 52 Week Low
  • NTRP $1.39
  • SYBX $0.90
  • 52 Week High
  • NTRP $8.50
  • SYBX $1.88
  • Technical
  • Relative Strength Index (RSI)
  • NTRP 41.73
  • SYBX 58.06
  • Support Level
  • NTRP $1.72
  • SYBX $1.00
  • Resistance Level
  • NTRP $2.21
  • SYBX $1.20
  • Average True Range (ATR)
  • NTRP 0.22
  • SYBX 0.05
  • MACD
  • NTRP 0.07
  • SYBX 0.01
  • Stochastic Oscillator
  • NTRP 49.35
  • SYBX 96.00

About NTRP NEXTTRIP INC

NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: